Strategic Partnerships Opportunity to leverage existing collaborations with Asieris Pharmaceuticals to expand regional commercialization rights, integrate bladder cancer diagnosis and treatment platforms, and accelerate market penetration in China, Taiwan, Hong Kong and Macau.

Always Ready Platform Promote the portable, single-use cystoscopy solution as a cost-effective, sterile alternative for hospitals and clinics seeking turnkey, infection-control compliant endoscopy tooling; highlight potential hospital procurement savings and workflow efficiency gains.

Product Expansion Capitalize on recent launches such as Uro-GHD and Hystero-V to cross-sell additional single-use endoscopy accessories and compatible visualization platforms to urology and gynecology departments across target accounts.

Regional Presence Emphasize operations in California and Washington with Asia-based production to support regional supply reliability, shorter lead times, and competitive pricing for North American and Asia-Pacific buyers.

Growth Readiness Position the company as a disruptor with a robust IP portfolio and ongoing patent activity as a differentiator; pursue pilot programs and initial deployments in mid-sized hospitals to demonstrate cost savings and clinical workflow improvements.